Australia looks to expand PET (positron emission tomography):
This article was originally published in Clinica
In an effort to improve the diagnosis of cancer in the state of Victoria, the Australian federal health department has funded the installation a combined positron emission tomography (PET) and computed tomography (CT) scanner at the Monash Medical Centre (MMC) in Moorabbin. The PET/CT scanner incorporates PET and CT technologies into a single device, allowing the collection of both anatomical and physiological information during a single examination. Data can then be viewed separately or superimposed on each other. Minister for health and aged care Senator Kay Patterson said that the new device would give many Australians access to this technology at minimal or not cost. The scanner will be managed by Australia's largest diagnostic imaging company, MIA Group, which will also gather information to assess the further expansion of PET funding.
You may also be interested in...
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.